BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8132238)

  • 1. Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):17-22. PubMed ID: 8132238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contranidatory activity of early luteal phase administration of mifepristone in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1993 Jan; 37(1):13-8. PubMed ID: 8449539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey.
    Nayak NR; Ghosh D; Lasley BL; Sengupta J
    Contraception; 1997 Feb; 55(2):103-14. PubMed ID: 9071520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early luteal phase administration of a single dose mifepristone on immunohistochemical distribution of interleukin 1 alpha (IL-1 alpha) and transforming growth factor beta 1 (TGF-beta 1) in mid-luteal phase ovary of the rhesus monkey.
    Sengupta S; Ghosh D
    Indian J Physiol Pharmacol; 2003 Apr; 47(2):221-4. PubMed ID: 15255629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; Sengupta J
    Hum Reprod; 1993 Apr; 8(4):552-8. PubMed ID: 8501184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys.
    Ghosh D; Sharkey AM; Charnock-Jones DS; Smith SK; Sengupta J
    Reproduction; 2009 Aug; 138(2):357-70. PubMed ID: 19439560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
    Ghosh D; Nayak NR; Sengupta J
    Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey.
    Ghosh D; Kumar PG; Sengupta J
    Hum Reprod; 1997 Mar; 12(3):575-82. PubMed ID: 9130762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
    Nayak NR; Sengupta J; Ghosh D
    Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women.
    Spitz IM; Shoupe D; Sitruk-Ware R; Mishell DR
    J Reprod Fertil Suppl; 1989; 37():253-60. PubMed ID: 2681741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone, but not luteal estrogen, is required for the establishment of pregnancy in the new world monkey Cebus apella.
    Ortiz ME; Ortiz RE; Garfield R; Zepeda AJ; Croxatto HB
    Am J Primatol; 2007 Oct; 69(10):1131-40. PubMed ID: 17387700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an antiprogesterone agent, RU-486, on the menstrual cycle of the rhesus monkey.
    Shortle B; Dyrenfurth I; Ferin M
    J Clin Endocrinol Metab; 1985 Apr; 60(4):731-5. PubMed ID: 3972971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of induced menses on symptoms in women with premenstrual syndrome.
    Schmidt PJ; Nieman LK; Grover GN; Muller KL; Merriam GR; Rubinow DR
    N Engl J Med; 1991 Apr; 324(17):1174-9. PubMed ID: 2011161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial tumor necrosis factor alpha (TNFalpha) is a likely mediator of early luteal phase mifepristone-mediated negative effector action on the preimplantation embryo.
    Lalitkumar PG; Sengupta J; Ghosh D
    Reproduction; 2005 Mar; 129(3):323-35. PubMed ID: 15749959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward developing a once-a-month pill: a double-blind, randomized, controlled trial of the effect of three single doses of mifepristone given at midcycle on the pattern of menstrual bleeding.
    Narvekar N; Glasier A; Dada K; Van der Spuy Z; Ho PC; Cheng L; Baird DT
    Fertil Steril; 2006 Oct; 86(4):819-24. PubMed ID: 17027354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey.
    Ghosh D; Lalitkumar PG; Wong VJ; Hendrickx AG; Sengupta J
    Hum Reprod; 2000 Jan; 15(1):180-8. PubMed ID: 10611210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.